These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38877472)

  • 1. Identification of the cytoplasmic DNA-Sensing cGAS-STING pathway-mediated gene signatures and molecular subtypes in prostate cancer.
    Yang J; Xu Z; Zheng W; Li Y; Wei Q; Yang L
    BMC Cancer; 2024 Jun; 24(1):732. PubMed ID: 38877472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular subtyping associated with the cGAS-STING pathway provides novel perspectives on the treatment of ulcerative colitis.
    Wang C; Gao X; Li Y; Li C; Ma Z; Sun D; Liang X; Zhang X
    Sci Rep; 2024 Jun; 14(1):12683. PubMed ID: 38831059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway.
    Li M; Bai G; Cen Y; Xie Q; Chen J; Chen J; Chen Q; Zhong W; Zhou X
    J Transl Med; 2023 Dec; 21(1):884. PubMed ID: 38057852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pleiotropic roles of cGAS-STING signaling in the tumor microenvironment.
    Li J; Bakhoum SF
    J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35325182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
    Zhuo X; Dai H; Yu S
    Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer.
    Kwon J; Bakhoum SF
    Cancer Discov; 2020 Jan; 10(1):26-39. PubMed ID: 31852718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients.
    Feng D; Wang J; Shi X; Li D; Wei W; Han P
    Eur J Med Res; 2023 May; 28(1):172. PubMed ID: 37179366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
    Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
    Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression.
    Ghosh M; Saha S; Li J; Montrose DC; Martinez LA
    Mol Cell; 2023 Jan; 83(2):266-280.e6. PubMed ID: 36638783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer.
    Kaneta A; Nakajima S; Okayama H; Matsumoto T; Saito K; Kikuchi T; Endo E; Ito M; Mimura K; Kanke Y; Saito M; Saze Z; Fujita S; Sakamoto W; Onozawa H; Momma T; Ohki S; Kono K
    Cancer Immunol Immunother; 2022 Nov; 71(11):2765-2776. PubMed ID: 35429245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entanglement of Methylation Changes and cGAS-STING Signaling in Non-Small-Cell Lung Cancer.
    Hao F
    Comb Chem High Throughput Screen; 2023; 26(1):224-235. PubMed ID: 35585823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin activates the cGAS-STING pathway by upregulating the TREX-1 (three prime repair exonuclease 1) expression in human melanoma.
    Ma Z; Xiong Q; Xia H; Liu W; Dai S; Cai S; Zhu Z; Yan X
    Bioengineered; 2021 Dec; 12(1):6448-6458. PubMed ID: 34519260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
    Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
    Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling.
    An Y; Zhu J; Xie Q; Feng J; Gong Y; Fan Q; Cao J; Huang Z; Shi W; Lin Q; Wu L; Yang C; Ji T
    Adv Sci (Weinh); 2024 May; 11(20):e2308131. PubMed ID: 38498770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Potential of a Novel Therapeutic Strategy for Colorectal Cancer Targeting the cGAS-STING Pathway].
    Nakajima S; Kaneta A; Kono K
    Gan To Kagaku Ryoho; 2023 Sep; 50(9):950-954. PubMed ID: 37800285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.